Ensysce Biosciences Inc - ESG Rating & Company Profile powered by AI
This webpage is a free ESG analysis covering Ensysce Biosciences Inc. Other corporations in the rating industry group for Ensysce Biosciences Inc are shownin the table. The Disclosure rating covers seventeen UN SDGs including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'.
Ensysce Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 8.0, social score of 1.6 and governance score of 8.0.
5.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 498 | Redx Pharma PLC | 6.0 | High |
| 498 | Vimta Labs Ltd | 6.0 | High |
| 521 | Ensysce Biosciences Inc | 5.9 | High |
| 521 | Cellink AB | 5.9 | High |
| 521 | Celon Pharma SA | 5.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ensysce Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Ensysce Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Ensysce Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Ensysce Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Ensysce Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ensysce Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ensysce Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Ensysce Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Ensysce Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Ensysce Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ensysce Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ensysce Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ensysce Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ensysce Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Ensysce Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Ensysce Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ensysce Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ensysce Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.